Cargando…
Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia
Background: Ataxia Telangiectasia (A-T) is a severe DNA repair disorder that leads to a broad range of symptoms including neurodegeneration and a variable immunodeficiency. A-T is one of the incidental findings that accompanies newborn screening (NBS) for severe combined immunodeficiency (SCID), lea...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851017/ https://www.ncbi.nlm.nih.gov/pubmed/31781088 http://dx.doi.org/10.3389/fimmu.2019.02438 |
_version_ | 1783469549178322944 |
---|---|
author | Blom, Maartje Schoenaker, Michiel H. D. Hulst, Myrthe de Vries, Martine C. Weemaes, Corry M. R. Willemsen, Michèl A. A. P. Henneman, Lidewij van der Burg, Mirjam |
author_facet | Blom, Maartje Schoenaker, Michiel H. D. Hulst, Myrthe de Vries, Martine C. Weemaes, Corry M. R. Willemsen, Michèl A. A. P. Henneman, Lidewij van der Burg, Mirjam |
author_sort | Blom, Maartje |
collection | PubMed |
description | Background: Ataxia Telangiectasia (A-T) is a severe DNA repair disorder that leads to a broad range of symptoms including neurodegeneration and a variable immunodeficiency. A-T is one of the incidental findings that accompanies newborn screening (NBS) for severe combined immunodeficiency (SCID), leading to an early diagnosis of A-T at birth in a pre-symptomatic stage. While some countries embrace all incidental findings, the current policy in the Netherlands on reporting untreatable incidental findings is more conservative. We present parents' perspectives and considerations on the various advantages vs. disadvantages of early and late diagnosis of A-T. Methods: A questionnaire was developed and sent to 4,000 parents of healthy newborns who participated in the Dutch SONNET-study (implementation pilot for newborn screening for SCID). The questionnaire consisted of open-ended and scale questions on advantages and disadvantages of early and late diagnosis of A-T. To address potential bias, demographic characteristics of the study sample were compared to a reference population. Results: A total of 664 of 4,000 parents sent back the questionnaire (response rate 16.6%). The vast majority of parents (81.9%) favored early diagnosis of A-T over late diagnosis. Main arguments were to avoid a long period of uncertainty prior to diagnosis and to ensure the most optimal clinical care and guidance from the onset of symptoms. Parents who favored late diagnosis of A-T stated that early diagnosis would not lead to improved quality of life and preferred to enjoy the asymptomatic “golden years” with their child. The majority of parents (81.1%) stated that they would participate in newborn screening for A-T if a test was available. Conclusions: Reporting untreatable incidental findings remains a disputed topic worldwide. Although the current policy in the Netherlands is not to report untreatable incidental findings, unless the health advantage is clear, the majority of parents of healthy newborns are in favor of an early A-T diagnosis in the pre-symptomatic phase of the disorder. Our results as well as other studies that showed support for the screening of untreatable disorders may serve as valuable tools to inform policymakers in their considerations about NBS for untreatable disorders. |
format | Online Article Text |
id | pubmed-6851017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68510172019-11-28 Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia Blom, Maartje Schoenaker, Michiel H. D. Hulst, Myrthe de Vries, Martine C. Weemaes, Corry M. R. Willemsen, Michèl A. A. P. Henneman, Lidewij van der Burg, Mirjam Front Immunol Immunology Background: Ataxia Telangiectasia (A-T) is a severe DNA repair disorder that leads to a broad range of symptoms including neurodegeneration and a variable immunodeficiency. A-T is one of the incidental findings that accompanies newborn screening (NBS) for severe combined immunodeficiency (SCID), leading to an early diagnosis of A-T at birth in a pre-symptomatic stage. While some countries embrace all incidental findings, the current policy in the Netherlands on reporting untreatable incidental findings is more conservative. We present parents' perspectives and considerations on the various advantages vs. disadvantages of early and late diagnosis of A-T. Methods: A questionnaire was developed and sent to 4,000 parents of healthy newborns who participated in the Dutch SONNET-study (implementation pilot for newborn screening for SCID). The questionnaire consisted of open-ended and scale questions on advantages and disadvantages of early and late diagnosis of A-T. To address potential bias, demographic characteristics of the study sample were compared to a reference population. Results: A total of 664 of 4,000 parents sent back the questionnaire (response rate 16.6%). The vast majority of parents (81.9%) favored early diagnosis of A-T over late diagnosis. Main arguments were to avoid a long period of uncertainty prior to diagnosis and to ensure the most optimal clinical care and guidance from the onset of symptoms. Parents who favored late diagnosis of A-T stated that early diagnosis would not lead to improved quality of life and preferred to enjoy the asymptomatic “golden years” with their child. The majority of parents (81.1%) stated that they would participate in newborn screening for A-T if a test was available. Conclusions: Reporting untreatable incidental findings remains a disputed topic worldwide. Although the current policy in the Netherlands is not to report untreatable incidental findings, unless the health advantage is clear, the majority of parents of healthy newborns are in favor of an early A-T diagnosis in the pre-symptomatic phase of the disorder. Our results as well as other studies that showed support for the screening of untreatable disorders may serve as valuable tools to inform policymakers in their considerations about NBS for untreatable disorders. Frontiers Media S.A. 2019-11-06 /pmc/articles/PMC6851017/ /pubmed/31781088 http://dx.doi.org/10.3389/fimmu.2019.02438 Text en Copyright © 2019 Blom, Schoenaker, Hulst, de Vries, Weemaes, Willemsen, Henneman and van der Burg. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Blom, Maartje Schoenaker, Michiel H. D. Hulst, Myrthe de Vries, Martine C. Weemaes, Corry M. R. Willemsen, Michèl A. A. P. Henneman, Lidewij van der Burg, Mirjam Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia |
title | Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia |
title_full | Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia |
title_fullStr | Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia |
title_full_unstemmed | Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia |
title_short | Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia |
title_sort | dilemma of reporting incidental findings in newborn screening programs for scid: parents’ perspective on ataxia telangiectasia |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851017/ https://www.ncbi.nlm.nih.gov/pubmed/31781088 http://dx.doi.org/10.3389/fimmu.2019.02438 |
work_keys_str_mv | AT blommaartje dilemmaofreportingincidentalfindingsinnewbornscreeningprogramsforscidparentsperspectiveonataxiatelangiectasia AT schoenakermichielhd dilemmaofreportingincidentalfindingsinnewbornscreeningprogramsforscidparentsperspectiveonataxiatelangiectasia AT hulstmyrthe dilemmaofreportingincidentalfindingsinnewbornscreeningprogramsforscidparentsperspectiveonataxiatelangiectasia AT devriesmartinec dilemmaofreportingincidentalfindingsinnewbornscreeningprogramsforscidparentsperspectiveonataxiatelangiectasia AT weemaescorrymr dilemmaofreportingincidentalfindingsinnewbornscreeningprogramsforscidparentsperspectiveonataxiatelangiectasia AT willemsenmichelaap dilemmaofreportingincidentalfindingsinnewbornscreeningprogramsforscidparentsperspectiveonataxiatelangiectasia AT hennemanlidewij dilemmaofreportingincidentalfindingsinnewbornscreeningprogramsforscidparentsperspectiveonataxiatelangiectasia AT vanderburgmirjam dilemmaofreportingincidentalfindingsinnewbornscreeningprogramsforscidparentsperspectiveonataxiatelangiectasia |